Recall Register

Device recall: Thermo Scientific Remel Bordetella pertussis Agglutinating Serum Product Number: R30165501, UDI-DI: 05056080501826 -…

Class II FDA enforcement event 86109. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Thermo Scientific" Remel" Bordetella pertussis Agglutinating Serum (R30165501/ZM10) is not performing, resulting in the potential for false negative results for serotypes 1 and 3

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

Remel Europe Ltd. started this device recall on 23 Jul 2020. The firm address in the FDA record is in Dartford. FDA put the recall in Class II. FDA event 86109 has 1 product record. The first FDA enforcement report date is 9 Sep 2020. The record gives the status Terminated, with the termination date 22 Mar 2022.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Worldwide distribution - US Nationwide distribution including in the states of MO, CA and the countries of CA, AT, BO, CN, CZ, GB, GM, HK, IE, IT, MX, MY, NL,OM, SA.

Recalling firm

Remel Europe Ltd., Dartford, N/A, United Kingdom.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 86109: product records
Recall numberProductQuantityClassStatusReport date
Z-2920-2020Thermo Scientific Remel Bordetella pertussis Agglutinating Serum Product Number: R30165501, UDI-DI: 05056080501826 - Product Usage: Bordetella antisera are suitable for use in slide agglutination tests to serologically identify Bordetella pertussis and Bordetella parapertussis for epidemiological and diagnostic…79 unitsClass IITerminated9 Sep 2020

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Device events that started in 2020
916
Share of these events in Class II
93%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
3

Other events of the firm

Other FDA enforcement events of Remel Europe Ltd.
InitiatedProduct (first record)TypeClassRecords
17 Jul 2026Thermo Fisher Diagnostics Neisseria meningitidis Gp C 2ml/VL, Product Number R30166901; invitro diagnosticsDeviceClass II1
25 Mar 2026Oxoid Agglutinating Sera, Salmonella 9-0 R30957301DeviceClass II1

Remel Europe Ltd.: all 3 events

Official channels

Cite this page

Recall Register. FDA enforcement event 86109. https://recallregister.com/fda/ii/86109/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA device enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Worldwide distribution - US Nationwide distribution including in the states of MO, CA and the countries of CA, AT, BO, CN, CZ, GB, GM, HK, IE, IT, MX, MY, NL,OM, SA.
What quantity of product is in FDA event 86109?
The FDA record gives this quantity: 79 units
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many device recalls of 2020 have the same class?
93% of the 916 device events that started in 2020 are in Class II.